12/05/2017 6o Συνέδριο Διακαθετηριακής Θεραπείας Καρδιακών Βαλβιδοπαθειών | N.Bouboulis | 3. Unanimous verdict: non TF patient but requires TAVR. Access selection path

 
997 VIEWS EXPANDCOLLAPSE PRESENTATION

Share

186,737 total
535 live
997 video
85,977 photo
Views:

11:30-13:30 TAVR club I
Πρόεδροι: G.Sianos,I.Mastorakou,I.Chlorogiannis,A.Dimas
11:30-11:45 1. MSCT screening. Guidance, device selection, and outcomes prediction
C.Mourmouris
11:45-12:00 2. TF access today: vessel, device and experience related minimum requirements, limits, techniques
G.Latsios
12:00-12:15 3. Unanimous verdict: non TF patient but requires TAVR. Access selection path
N.Bouboulis
12:15-12:30 4. Concomitant coronary artery disease: significance and an individualized treatment approach
V.Tzifos
12:30-12:45 5. The advanced renal failure and the on renal replacement patient. Planning, techniques, device selection, valve durability and other issues
E.Skalidis
12:45-13:00 6. The procedure was flawless but unfortunately the patient never made it to home. Why and how to avoid this in the future
K.Toutouzas
13:00-13:20 7. TAVR live-in-a-box
K.Spargias
13:20-13:30 Συζήτηση


 
Sort by Date | Views
Watch live and on demand the '6th Conference of  Transcatheter Heart Valve Therapies'.
​
The Diagnostic and Therapeutic Center of Athens Hygeia organizes the '6th Conference of  Transcatheter Heart Valve Therapies' that will take place from 12 to 13 May 2017, at Hilton Hotel in Athens, Greece.

For more information please click here.

Παρακολουθήστε ζωντανά και on demand το '6ο Συνέδριο Διαδερμικής Θεραπείας Καρδιακών Βαλβιδοπαθειών'.

Το Διαγνωστικό Θεραπευτικό Κέντρο Αθηνών ΥΓΕΙΑ διοργανώνει το '6o Συνέδριο Διαδερμικής Θεραπείας Καρδιακών Βαλβιδοπαθειών' στις 12 - 13 Μαΐου 2017 στο ξενοδοχείο Hilton στην Αθήνα.

Για περισσότερες πληροφορίες, πατήστε εδώ.
A.Manginas | 1. The foundation of a new... 1.178
K.Spargias | 2. TAVR: The device evolution... 1.248
K.Toutouzas | 3. TAVR: The constantly changing... 1.079
G.Latsios | 4. What is the reasonable training... 1.169
K.Bellos | 5. What is the reasonable training... 1.089
A.Manolis | 6. Who should be performing... 1.793
I.Iakovou | 7. TAVI live case-in-a-box 1.307
S.Pattakos 1.054
460
D.Cokkinos 1.210
A.Kartapanis 1.024
I.Goudevenos 1.047
Στρατής Παττακός | Καρδιοχειρουργός, Διευθυντής... 1.322
1:24
Στέφανος Φούσας | Σ. Διευθυντής - Ε. Καθηγητής... 924
2:31
C.Mourmouris | 1. MSCT screening. Guidance,... 1.004
Catherine Avgeropoulou, Cardiologist, Director,... 1.084
1:49
Konstantinos Toutouzas | Associate Professor... 1.326
2:08
G.Latsios | 2. TF access today: vessel,... 970
Gregory Pavlides | MD, PhD, FACC, FESC, Professor... 1.167
2:08
N.Bouboulis | 3. Unanimous verdict: non... 997
V.Tzifos | 4. Concomitant coronary artery... 990
E.Skalidis | 5. The advanced renal failure... 1.107
K.Toutouzas | 6. The procedure was flawless... 1.076
K.Spargias | 7. TAVR live-in-a-box 1.118
C.Avgeropoulou | 1. A “Physiologist’s” view... 1.149
C.Chrysohoou | 2. From clinical practice... 1.107
G.Makos | 4. MR Surgery. When to repair... 1.111
G.Pavlides | 5. Trancatheter MV replacement.... 1.073
K.Spargias | 6. MAC and ViV, ViR 1.029
K.Spargias | 7. Mitraclip case-in-a-box 1.156
K.Spargias | 1. The “standardized” TAVR... 895
Konstantinos Spargias | Director, Transcatheter... 1.502
1:56
George Dangas | FESC, FACC, Professor of... 1.100
2:10
L.Papavasileiou | 2. Pacemaker need after... 1.038
A.Kostopoulou | 3. Pacemaker indication:... 1.261
J.Velianou | 4. Why I want to move to lower... 1.062
V. Andoutsopoulou | 5. What bothers me to... 1.304
G.Dangas | 6. Antiplatelet/anticoagulation... 1.146
C.Arampatzis | 7. My best and worst TAVR... 1.023
K.Raisakis | 1. My best and worst TAVR case... 1.177
V.Tzifos | 2. My best and worst TAVR case... 1.088
P.Davlouros | 3. My best and worst TAVR... 1.157
M.Ηamilos | 4. My best and worst TAVR case... 878
A.Zacharoulis | 5. My best and worst TAVR... 979
A.Synetos | 6. My best and worst TAVR case... 1.185
K.Papadopoulos | 8. My best and worst TAVR... 1.095
Andreas Synetos | MD, PhD, FESC, Cardiologist,... 1.091
1:24
V.Ninios | 1. MitraClip patient selection-... 1.079
V.Ninios | 1. MitraClip patient selection-... 1.017
G.Pavlides | 3. Mitral interventions: a... 1.059
S.Pattakos | 6. Which “operable” DMR patient... 1.036
V.Ninios | 7. Mitraclip case-in-a-box 911
M.Vavouranakis | 1. How I select my TAVR... 1.015
K.Spargias | 2. How I select my TAVR device?... 1.000
D.Nikas | 4. How I select my TAVR device?... 993
D.Nikas | 4. How I select my TAVR device?... 765
Q&A / Comments 988
K. Papadopoulos - K.Spargias | 6. TAVR live-in-a-box 1.043
A.Gkouziouta | 1. The pathophysiology of... 1.166
I.Ikonomidis | 2. Assessing Tricuspid Regurgitation:... 1.104
P.Sfyridis | 3. The unforgotten valve: what... 983
V.Sachpekidis | 5. The multiple valve disease... 1.078
V.Ninios | 6. Mitraclip in TR 926
M.Chrissoheris | 7. FORMA in TR 1.018
G.Stavridis | 8. The isolated TR inoperable... 1.055
Q&A / Comments 1.049
VIDEO UNDER EDITING - L.Michalis | 1. TAVR:... 1.115
D.Angouras | 2. TAVR device durability.... 1.064
L.Poulimenos | 3. Paradox AVS: implications... 1.205
P.Dardas | 4. TAVR in Bicuspid and ViV 968
I.Iakovou | 5. VARC-2 and MVRC definitions 1.081
G.Bompas | 6. The concept of 4D imaging... 1.080
D.Nikas | 7. My best and worst TAVR case... 881
A.Ziakas | 3. My best and worst TAVR case... 1.138
N.Pilatis | 1. My best and worst TAVR case... 859
G.Karavolias | 4. My best and worst TAVR... 1.062
K.Kalogeras | 5. My best and worst TAVR... 818
D.Tsikaderis | 6. My best and worst TAVR... 1.087
A.Manginas | 7. My best and worst TAVR case... 1.077
P. Kourkoveli | 2. My best and worst TAVR... 1.047
Christina Chrysohoou, MD, Cardiologist,Heart... 989
49
Irene Mastorakou, Cardiac Radiologist,Director,... 906
123
Lampros Michalis, Professor of Cardiology,University... 1.217
49
James Velianou, MD, FRCPC,Interventional... 1.075
69
Georgios Katsimagklis, InterventionalCardiologist,... 1.389
109